Sven T Pleger

Summary

Affiliation: University of Heidelberg
Country: Germany

Publications

  1. doi request reprint One year clinical efficacy and reverse cardiac remodelling in patients with severe mitral regurgitation and reduced ejection fraction after MitraClip implantation
    Sven T Pleger
    Department of Internal Medicine III, Division of Cardiology, Im Neuenheimer Feld 410, University of Heidelberg, D 69120 Heidelberg, Germany
    Eur J Heart Fail 15:919-27. 2013
  2. pmc Long-term survival of cancer patients compared to heart failure and stroke: a systematic review
    Vasileios Askoxylakis
    Department of Radiooncology and Radiation Therapy, University of Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany
    BMC Cancer 10:105. 2010
  3. ncbi request reprint C-reactive protein kinetics and its prognostic value after transfemoral aortic valve implantation
    Ulrike Krumsdorf
    Department of Cardiology, University of Heidelberg, Heidelberg, Germany
    J Invasive Cardiol 24:282-6. 2012
  4. ncbi request reprint Percutaneous edge-to-edge repair of mitral regurgitation as a bail-out strategy in critically ill patients
    Sven T Pleger
    Department of Cardiology, University of Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany
    J Invasive Cardiol 25:69-72. 2013
  5. doi request reprint Acute safety and 30-day outcome after percutaneous edge-to-edge repair of mitral regurgitation in very high-risk patients
    Sven T Pleger
    Department of Cardiology, University of Heidelberg, Heidelberg, Germany
    Am J Cardiol 108:1478-82. 2011
  6. doi request reprint Preserved prognostic value of preinterventional troponin T levels despite successful TAVI in patients with severe aortic stenosis
    Emmanuel Chorianopoulos
    Department of Cardiology, Angiology and Pulmology, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany
    Clin Res Cardiol 103:65-72. 2014
  7. doi request reprint Heart failure gene therapy: the path to clinical practice
    Sven T Pleger
    Center for Molecular and Translational Cardiology, Department of Internal Medicine III, Germany
    Circ Res 113:792-809. 2013
  8. doi request reprint S100A1 gene therapy in small and large animals
    Patrick Most
    Department of Internal Medicine III, Center for Molecular and Translational Cardiology, University of Heidelberg, Heidelberg, Germany
    Methods Mol Biol 963:407-20. 2013

Collaborators

Detail Information

Publications8

  1. doi request reprint One year clinical efficacy and reverse cardiac remodelling in patients with severe mitral regurgitation and reduced ejection fraction after MitraClip implantation
    Sven T Pleger
    Department of Internal Medicine III, Division of Cardiology, Im Neuenheimer Feld 410, University of Heidelberg, D 69120 Heidelberg, Germany
    Eur J Heart Fail 15:919-27. 2013
    ..The aim of the present study was to investigate 1 year clinical and functional efficacy of percutaneous mitral valve (MV) repair using MitraClip in high-risk surgical patients with symptomatic severe MV regurgitation (MR) and reduced LVEF...
  2. pmc Long-term survival of cancer patients compared to heart failure and stroke: a systematic review
    Vasileios Askoxylakis
    Department of Radiooncology and Radiation Therapy, University of Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany
    BMC Cancer 10:105. 2010
    ..Aim of this study is to provide an overview of long term survival of cancer, heart failure and stroke patients based on the results of large population- and hospital-based studies...
  3. ncbi request reprint C-reactive protein kinetics and its prognostic value after transfemoral aortic valve implantation
    Ulrike Krumsdorf
    Department of Cardiology, University of Heidelberg, Heidelberg, Germany
    J Invasive Cardiol 24:282-6. 2012
    ..An infection should be taken into account if CRP increases above 110 mg/L and if patients show other signs of infection. Elevated CRP at baseline and at day 3 is associated with higher 30-day mortality...
  4. ncbi request reprint Percutaneous edge-to-edge repair of mitral regurgitation as a bail-out strategy in critically ill patients
    Sven T Pleger
    Department of Cardiology, University of Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany
    J Invasive Cardiol 25:69-72. 2013
    ..In addition, it demonstrates the applicability of this treatment in unstable and critically ill conditions as a tool for acute stabilization...
  5. doi request reprint Acute safety and 30-day outcome after percutaneous edge-to-edge repair of mitral regurgitation in very high-risk patients
    Sven T Pleger
    Department of Cardiology, University of Heidelberg, Heidelberg, Germany
    Am J Cardiol 108:1478-82. 2011
    ..At 1-month follow-up most patients showed persistent improvement in mitral regurgitation and a clinical benefit...
  6. doi request reprint Preserved prognostic value of preinterventional troponin T levels despite successful TAVI in patients with severe aortic stenosis
    Emmanuel Chorianopoulos
    Department of Cardiology, Angiology and Pulmology, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany
    Clin Res Cardiol 103:65-72. 2014
    ..Transcatheter aortic valve implantation (TAVI) has improved prognosis for patients without a surgical option. Whether this affects the prognostic value of preinterventional troponin T remains unclear...
  7. doi request reprint Heart failure gene therapy: the path to clinical practice
    Sven T Pleger
    Center for Molecular and Translational Cardiology, Department of Internal Medicine III, Germany
    Circ Res 113:792-809. 2013
    ..The objective of this review is to discuss the current state of the art in the field and point out inevitable innovations on which the future evolution of heart failure gene therapy into an effective and safe clinical treatment relies. ..
  8. doi request reprint S100A1 gene therapy in small and large animals
    Patrick Most
    Department of Internal Medicine III, Center for Molecular and Translational Cardiology, University of Heidelberg, Heidelberg, Germany
    Methods Mol Biol 963:407-20. 2013
    ..Here we describe myocardial gene therapy in small and large animal models of postischemic heart failure used to reveal the positive inotrope, antihypertrophic, and pro-energetic action of the small calcium sensor protein S100A1...